APVO Stock Analysis: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$3.95
-0.16 (-3.89%)
▼
5d:
-6.18%
30d:
-11.63%
90d:
-19.72%
HOLD
MODERATE Confidence
Analysis Updated: Jul 30, 2026 12:00 AM ET
Earnings: Aug 10, 2026
6d
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $3.95, which is considered oversold relative to its 30-day fair value range of $4.13 to $4.61.
Technical Outlook: Technically, APVO is showing sideways momentum. The price is currently testing key support at $3.90. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: APVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+520.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APVO is showing sideways momentum. The price is currently testing key support at $3.90. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: APVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+520.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.13 -
$4.61
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 520.4% below Wall St target ($25.50)
- CAUTION: 5-day price weakness (-6.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.13 -
$4.61
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.90
Resistance Level
$4.61
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.19
Wall Street Target
$25.50
(+520.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 03, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
